Subscribe to Newsletter
Manufacture Facilities
Taking Sustainability to Heart: An Interview With ten23 Health

| Stephanie Sutton | 11 min read

We sit down with Hanns-Christian Mahler, CEO of ten23 health.

Manufacture Bioprocessing - Upstream & Downstream

Less Patience, More Patients

| 4 min read

Sitting Down With Dick Sundh, General Manager, Kite Pharma

Discovery & Development Drug Discovery

The FLEET of Hope

| Robert H Cichewicz | 3 min read

Fungal infections and antifungal resistance are a significant problem; here’s one approach to consider

Register to personalize your newsfeed
Create Account

Latest Articles

Manufacture Facilities

Center of Excellence Opens for RNA

| Stephanie Sutton | 4 min read

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

Manufacture Advanced Medicine

Cell yourself

| Molly Mjolsness | 5 min read

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

Manufacture Bioprocessing - Upstream & Downstream

Getting More from Your Buffer Management Strategy

| Sponsored by Asahi Kasei Bioprocess | 7 min read

We delve into the story behind Lonza’s collaboration with Asahi Kasei Bioprocess America.

Manufacture Technology and Equipment

Tooling Up for Biopharma’s Digital Future

| Sponsored by Sartorius | 7 min read

How digitalization will revolutionize the way we develop and optimize bioprocesses.

Manufacture Bioprocessing - Upstream & Downstream

Planes, Trains, and Autologous Therapies

| Sumukhi Sreevatsan | 3 min read

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

Discovery & Development Drug Discovery

Meet an AI Model that Predicts Teratogenicity

| Jamie Irvine | 3 min read

Researchers demonstrate that complex data analysis paired with artificial intelligence can predict additional causes of Teratogenicity

Discovery & Development Drug Discovery

CRISPR With Caution

| Rob Coker | 3 min read

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

Discovery & Development Drug Discovery

Addressing Alzheimer’s

| 3 min read

The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it

Discovery & Development Drug Discovery

Alzheimer’s Treatment Timeline

| Stephanie Sutton | 2 min read

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

Discovery & Development Drug Discovery

Fabulously Interesting

| 6 min read

Sitting Down With… Sharon L Rogers, AmyriAD CEO, Renowned drug developer, 2023 Power Lister, and Olympic figure skating official

All Articles

Upcoming Events

-
Cell & Gene Meeting on the Mesa

Carlsbad, CA, USA

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and...

-
2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference, Gothenburg, Sweden

Gothenburg, Sweden

We are pleased to inform you, that PDA‘s signature event “The Universe of Pre-Filled Syringes and Injection Devices...

-
5th Annual Gene Therapy Analytical Development Summit

Boston, MA, USA

Uniting 400+ analytical experts to explore how the latest analytical methods are being developed and applied to...

All Events


Discovery & Development
Manufacture
Business & Regulation
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register